Close Menu

NEW YORK ─ Ortho Clinical Diagnostics on Monday announced it has received the CE mark for an antigen test to detect active SARS-CoV-2 infection, enabling its use in Europe and other countries that accept such designation.

The Raritan, New Jersey-based diagnostics company said it has also submitted an Emergency Use Authorization request to the US Food and Drug Administration for its Vitros SARS-CoV-2 Antigen test.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.